To examine the relation of electroencephalographic abnormalities to 5-year outcomes in first-episode psychosis (FEP).
Methods:
Patients (n = 103) had their baseline electroencephalogram (EEG) classified by modified Mayo Clinic criteria. Symptoms and psychosocial functioning were rated after 5 years of treatment.
Results:
Dysrhythmic EEG was associated with persistence in positive and negative symptoms of psychoses and poorer psychosocial functioning at 5-year follow-up, independently of other characteristics, such as duration of untreated illness or premorbid adjustment. A higher percentage of people with comorbid substance use disorder had normal EEG.
Conclusions:
Abnormal baseline EEG in FEP is associated with poorer 5-year symptomatic and functional outcome.
MerloMCKleinlogelHKoukkouM.Differences in the EEG profiles of early and late responders to antipsychotic treatment in first-episode, drug-naive psychotic patients. Schizophr Res. 1998;30(3):221–228.
2.
ManchandaRMallaAHarricharanR, EEG abnormalities and outcome in first-episode psychosis. Can J Psychiatry. 2003;48(11):722–726.
3.
ManchandaRNormanRMallaA, EEG abnormalities and 3-year outcome in first episode psychosis. Acta Psychiatr Scand. 2008;117(4):277–282.
4.
ManchandaRNormanR.Prevention and Early Intervention Program for Psychoses (PEPP) [Internet]. London (ON): PEPP; 2014 [cited date unknown]. Available from: http://www.pepp.ca.
5.
FirstMBSpitzerRLGibbonM, SCID Clinician Version administration booklet. New York (NY): State Psychiatric Institute, Biometrics Research Department; 1995.
6.
AndreasenNC. Scale for the Assessment of Positive Symptoms. Iowa City (IA): University of Iowa; 1984.
7.
AndreasenNC. Scale for the Assessment of Negative Symptoms. Iowa City (IA): University of Iowa Press; 1983.
8.
GoldmanHHSkodolAELaveTR. Revising Axis V for DSM-IV: A review of measures of social functioning. Am J Psychiatry. 1992;149(9):1148–1156.
9.
SusserEFinnertyMMojtabaiR, Reliability of the life chart schedule for assessment of the long-term course of schizophrenia. Schizophr Res. 2000;42(1):67–77.
10.
Cannon-SpoorHEPotkinSGWyattRJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470–484.
11.
Mayo Clinic. Clinical examination in neurology. Rochester (MN): Mayo Clinic and Mayo Foundation for Medical Education and Research; 1991.
12.
CrumlishNWhittyPClarkeM, Beyond the critical period: Longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br J Psychiatry. 2009;194(1):18–24.
13.
YucelMBoraELubmanDI, The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull. 2012;38(2):316–330.
14.
PillaySSStollALWeissMK, EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Ann Clin Psychiatry. 1996;8(1):1–5.
